Australia TGA Pharmaceutical Identification and Traceability Requirements

Discover OneScan

Global Regulations

Icon graphic element
Labelling

Products are required to display information in writing.

Summary

Australia regulates medicines through the Therapeutic Goods Administration (TGA). The country does not currently operate a national pharmaceutical serialization and verification system similar to those implemented in the European Union, Türkiye, or the United States.

The Australian regulatory framework focuses on product identification, supply chain documentation, and compliance with Good Manufacturing Practice and Good Distribution Practice. These controls support medicine traceability, product recall management, and protection against counterfeit medicines.

Manufacturers, importers, sponsors, wholesalers, and pharmacies must maintain clear records of product distribution and ensure medicines supplied to the Australian market are properly identified and traceable throughout the supply chain.

Labelling Requirements 

Pharmaceutical products supplied to Australia must comply with TGA labeling requirements defined in the Therapeutic Goods Orders and labeling standards.

Key traceability information that must appear on medicine packaging includes:

  • Product name and strength
  • Batch or Lot Number
  • Expiry Date
  • Sponsor information

Machine readable barcodes may be used to support supply chain scanning and identification. Barcodes typically encode the GTIN or other product identification number used for inventory and supply chain management.

Human readable information printed on the packaging must match the encoded barcode information where barcodes are used.

Serialization of individual medicine packs is not mandated by the TGA.

Regulatory Timeline 

  • 1989 – Therapeutic Goods Administration established to regulate medicines and medical devices in Australia.
  • 2000s – Expansion of electronic regulatory systems including the Australian Register of Therapeutic Goods.
  • 2010 onward – Continued strengthening of Good Manufacturing Practice and Good Distribution Practice requirements to support supply chain traceability.
  • Australia continues to monitor international serialization developments while maintaining a batch level traceability framework.

Reporting Requirements 

Operation
Data to Report
When to Report
Product Registration
Product details submitted to the Australian Register of Therapeutic Goods (ARTG)
Before market authorization
Batch Identification
Batch or lot number and expiry date
During manufacturing and packaging
Import Documentation
Product identification, batch details, and shipment documentation
During importation
Distribution Records
Batch number, product identification, and shipment records
During supply chain transfers
Recall Support
Batch identification and distribution records
During product recalls or investigations

‍

Traceability in Australia is primarily maintained at the batch level rather than at the individual pack serialization level.

Operational Timelines for Industry 

  • Register medicines in the Australian Register of Therapeutic Goods before placing products on the market.
  • Ensure packaging includes required product identification, batch numbers, and expiry information.
  • Maintain batch level traceability records for manufacturing, importation, and distribution.
  • Ensure wholesalers and distributors maintain accurate supply chain documentation.
  • Maintain recall readiness by ensuring batch distribution records are complete and accessible.
  • Provide traceability records to the TGA during regulatory inspections or product safety investigations.

‍

Reporting Hub

Australia does not operate a national pharmaceutical serialization repository or centralized track and trace reporting platform.

Traceability is maintained through:

  • Supply chain documentation
  • Distribution records maintained by sponsors and wholesalers
  • Batch level traceability records maintained by manufacturers and importers

The TGA relies on regulatory inspections, supply chain records, and recall procedures to monitor medicine distribution and investigate quality or safety concerns.

Aggregation Requirements 

There is no national regulatory requirement for packaging aggregation or serialized parent child hierarchies in Australia.

Manufacturers and distributors may implement aggregation structures internally to improve warehouse operations, shipment management, and supply chain efficiency.

Logistics units such as cases and pallets may use SSCC identifiers for internal supply chain tracking.

‍

Common Errors to Avoid 

  • Incomplete batch identification on pharmaceutical packaging.
  • Mismatch between packaging information and batch records maintained in distribution systems.
  • Failure to maintain accurate distribution records needed for product recalls.
  • Poor barcode quality that prevents reliable scanning during warehouse or distribution operations.
  • Lack of documented traceability procedures across manufacturing and distribution activities.

Trusted by Industry Leaders

Smooth and Successful

LSPedia didn’t just provide software; they ensured we were fully compliant. Anytime we had questions, the LSPedia team knew DSCSA inside and out and guided us step by step. That level of expertise made a huge difference during audits. Thanks to their expert team our audit was smooth and successful

Hussein Salman
Lead Pharmacist, Pioneer Pharmacy Services

Constant Commitment

LSPedia shows a constant commitment to improvement; whether it's their support or their product...they're always leveling up. The support team provides consistently thorough follow-up and clear, articulate communication. the support we receive represents a meaningful step up in service and is genuinely appreciated.

Zac Sweeny
EPCIS Data Encoder,Capital Wholesale Drug
Read All TestimonialsView Our Customers

Fill in the form for latest updates

Get in Touch

We invite you to learn more about how LSPedia can support your compliance and supply chain needs. For more information about our solutions, partnership opportunities, or to speak with one of our experts.

Contact Us